CurAegis (CRGS) 10-Q 9 May 18 2018 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 09, 2018
Document Information [Line Items]
Entity Registrant Name	CurAegis Technologies, Inc.
Entity Central Index Key	1,063,197
Trading Symbol	crgs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		49,809,546
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current Assets:
Cash	$ 192,000	$ 194,000
Accounts receivable	14,000	8,000
Inventory (net)	1,741,000	1,744,000
Prepaid expenses and other current assets	27,000	27,000
Total current assets	1,974,000	1,973,000
Software (net)	71,000	102,000
Property and equipment (net)	112,000	125,000
Total non-current assets	183,000	227,000
Total Assets	2,157,000	2,200,000
Current Liabilities:
Accounts payable	162,000	167,000
Liability for inventory held at vendor	1,512,000	1,678,000
Other current liabilities	149,000	103,000
Accrued interest	105,000	87,000
Deferred revenue	24,000	5,000
Capital lease obligation - current	2,000	2,000
Total current liabilities	1,954,000	2,042,000
Capital lease obligation, non-current	2,000	3,000
Senior convertible notes (net)	4,683,000	3,563,000
Total Liabilities	6,639,000	5,608,000
Commitments
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at March 31, 2018 and December 31, 2017: 49,059,546 and 48,979,546 respectively	491,000	490,000
Additional paid-in capital	76,715,000	76,494,000
Accumulated deficit	(82,136,000)	(80,841,000)
Total Stockholders' Deficit	(4,482,000)	(3,408,000)
Total Liabilities and Stockholders' Deficit	2,157,000	2,200,000
Preferred Class C [Member]
Current Liabilities:
Preferred stock, value	159,000	159,000
Series C2 Preferred Stock [Member]
Current Liabilities:
Preferred stock, value	250,000	250,000
Series C3 Preferred Stock [Member]
Current Liabilities:
Preferred stock, value	33,000	34,000
Preferred Class A [Member]
Current Liabilities:
Preferred stock, value	5,000	5,000
Preferred Class B [Member]
Current Liabilities:
Preferred stock, value	$ 1,000	$ 1,000

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	49,059,546	48,979,546
Common stock, shares outstanding (in shares)	49,059,546	48,979,546
Preferred Class C [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	15,937,500	15,937,500
Preferred stock, shares outstanding (in shares)	15,937,500	15,937,500
Series C2 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	25,000,000	25,000,000
Preferred stock, shares outstanding (in shares)	25,000,000	25,000,000
Series C3 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	3,308,000	3,388,000
Preferred stock, shares outstanding (in shares)	3,308,000	3,388,000
Preferred Class A [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.40	$ 0.40
Preferred stock, shares issued (in shares)	468,221	468,221
Preferred stock, shares outstanding (in shares)	468,221	468,221
Preferred Class B [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.50	$ 0.50
Preferred stock, shares issued (in shares)	67,500	67,500
Preferred stock, shares outstanding (in shares)	67,500	67,500

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenue	$ 8,000	$ 9,000
Cost of revenue	37,000	37,000
Loss on Revenue	(29,000)	(28,000)
Engineering and development:
E&D costs, excluding stock-based compensation	426,000	485,000
Stock-based compensation	(21,000)	8,000
Total engineering and development	405,000	493,000
General and administrative:
G&A costs, excluding stock-based compensation	602,000	730,000
Stock-based compensation	23,000	95,000
Total general and administrative	625,000	825,000
Total costs and expenses	1,030,000	1,318,000
Loss from operations	(1,059,000)	(1,346,000)
Interest expense	(237,000)	(156,000)
Other income	1,000	1,000
Non-operating (expense)	(236,000)	(155,000)
Loss before income taxes	(1,295,000)	(1,501,000)
Income taxes
Net Loss	(1,295,000)	(1,501,000)
Preferred stock dividends	54,000	62,000
Net Loss attributable to common stockholders	$ (1,349,000)	$ (1,563,000)
Net Loss per share attributable to common stockholders:
Basic and Diluted (in dollars per share)	$ (0.03)	$ (0.03)
Weighted average number of shares of common stock:
Basic and Diluted (in shares)	49,031,000	47,161,000

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($)	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series C2 Preferred Stock [Member]	Preferred Stock [Member]Series C3 Preferred Stock [Member]	Preferred Stock [Member]Preferred Class A [Member]	Preferred Stock [Member]Preferred Class B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Series C3 Preferred Stock [Member]	Total
Balance (in shares) at Dec. 31, 2017	15,937,500	25,000,000	3,388,000	468,221	67,500	48,979,546
Balance at Dec. 31, 2017	$ 159,000	$ 250,000	$ 34,000	$ 5,000	$ 1,000	$ 490,000	$ 76,494,000	$ (80,841,000)		$ (3,408,000)
Conversion Preferred C-3 to common stock (in shares)			(80,000)			80,000			80,000
Conversion Preferred C-3 to common stock			$ (1,000)			$ 1,000
Stock-based compensation							2,000			2,000
Issuance of warrants with convertible notes							208,000			208,000
Beneficial conversion feature on convertible note							11,000			11,000
Net Loss								(1,295,000)		(1,295,000)
Balance (in shares) at Mar. 31, 2018	15,937,500	25,000,000	3,308,000	468,221	67,500	49,059,546
Balance at Mar. 31, 2018	$ 159,000	$ 250,000	$ 33,000	$ 5,000	$ 1,000	$ 491,000	$ 76,715,000	$ (82,136,000)		$ (4,482,000)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net loss	$ (1,295,000)	$ (1,501,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	44,000	46,000
Amortization of discount reported as interest	139,000	112,000
Stock-based compensation	2,000	103,000
Changes in working capital items:
Accounts receivable	(6,000)	10,000
Inventory	3,000	(11,000)
Prepaid expenses and other current assets		4,000
Accounts payable and other accrued expenses	(108,000)	128,000
Deferred revenue	19,000	(7,000)
Net cash used in operating activities	(1,202,000)	(1,116,000)
Cash flows from investing activities:
Purchase of property, equipment and software		(11,000)
Net cash used in investing activities		(11,000)
Cash flows from financing activities:
Proceeds from issuance of senior convertible note	1,200,000
Proceeds from exercise of common stock warrant		10,000
Net cash provided by financing activities	1,200,000	10,000
Net decrease in cash	(2,000)	(1,117,000)
Cash at beginning of period	194,000	2,009,000
Cash at end of period	192,000	892,000
Supplemental Disclosures:
Cash used for payment of interest	$ 80,000

Note 1 - The Company and Basis

Note 1 - The Company and Basis of Presentation	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 2016 two The Company develops and markets advanced technologies in the areas of safety, wellness and power. The Company is focused on the commercialization of a wellness and safety system (the CURA System and the myCadian watch) and a uniquely designed hydraulic pump that will be smaller, lighter and more efficient than current technology. The Company has not The Company has created the CURA System to market products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA System consists of the following capabilities: ● the myCadian watch and app, ● real-time alertness monitoring, ● the Group Wellness Index and ● the Z-Coach wellness program. Our goal with the Aegis hydraulic pump technology is to bring to the marketplace a unique concept in hydraulic pumps and motors that will be: ● smaller and lighter than conventional pumps and motors, ● more efficient, ● as reliable, ● price competitive, and ● unique in its ability to scale larger, allowing more powerful pumps and motors. It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Current Cash Outlook and Management Plans As of March 31, 2018, $192,000, $20,000, $4,482,000 $82,136,000. three March 31, 2018 $1,200,000 6% Management estimates that the 2018 $4.5 $5.0 March 31, 2018, not Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No may may may not The Company’s ability to fund its current and future commitments from its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA division; (ii) generate revenue from the licensing or sale of our hydraulic technologies; or (iii) decrease engineering and development and administrative expenses. If these and other factors are not no

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2 Basis of Presentation: 10 8 03 X not not December 31, 2017 2017 10 Consolidation: 56% March 31, 2018, Use of Estimates: Reclassifications: may Cash: may $15,000. Inventory $6,000 March 31, 2018 December 31, 2017, Accounts Receivable not zero March 31, 2018 December 31, 2017. Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in Other income. Depreciation and software amortization expense for the three March 31, 2018 2017 $44,000 $46,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may During the three March 31, 2018 March 31, 2017 no Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 March 31, 2018 December 31, 2017. 6% $7,949,000 March 31, 2018 March 31, 2018. Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. not not two The Company's net revenue is derived primarily from domestic customers. For the three March 31, 2018 $4,000 $4,000. Revenue from the sale of CURA System products is recognized upon the shipment of myCadian devices to a customer and upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30 One customer accounted for 87% three March 31, 2018. 30 Engineering and Development and Patents: Patent costs for the three March 31, 2018 March 31, 2017 $31,000 $30,000, Stock-based Compensation: 718 10 718 10. No FASB ASC 505 50, FASB ASC 718 20 Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not March 31, 2018, December 31, 2017, no Loss per Common Share: 260 10 March 31, 2018 2017 84,560,427 72,282,657 625,000 March 31, 2018 2017 not Recent Accounting Pronouncements : In May 2017, No. 2017 09 718 December 15, 2017 not In June 2016, No. 2016 13 326 not December 15, 2019, not On February 25, 2016, No. 2016 02, December 15, 2018, not

Note 3 - Inventory and Related

Note 3 - Inventory and Related Vendor Liability	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 3 The Company had the following inventory held at our manufacturing vendor and on hand as of March 31, 2018 December 31, 2017: March 31, December 31, 2018 2017 Raw materials $ 1,681,000 $ 1,681,000 Finished goods 66,000 69,000 1,747,000 1,750,000 Less: Reserve for quality (6,000 ) (6,000 ) Inventory (net) $ 1,741,000 $ 1,744,000 Liability for inventory held at vendor $ 1,512,000 $ 1,678,000 During 2017, March 31, 2018, $1,681,000 $1,512,000

Note 4 - 6% Senior Convertible

Note 4 - 6% Senior Convertible Notes and Warrants	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 4 6% 2017 Face value of 2017 Convertible Notes $ 4,026,000 Debt discount at issuance (1,743,000 ) 2017 extinguishment impact on discount 1,183,000 Amortization of debt discount since inception 99,000 2017 Senior Convertible Notes (net) $ 3,565,000 The board of directors has authorized the issuance of up to $5 6% “2017 May 31, 2017 “2017 2017 five 6%. first The conversion rate of the notes was originally fixed at $0.50 May 31, 2017 November 30, 2017 $0.333 $500,000 10% $500,000 25% $0.50 ten November 30, 2017 $0.333 $2,450,000 fourth 2017, $0.50 $0.333 $0.50 $0.333 2017 2017. The 2017 4 2 1934, 506 501 1933. The Company issued $1,200,000 three March 31, 2018 3,603,604 777,027 $219,000 first 2018 During the three March 31, 2018, $74,000 $21,000. March 31, 2018, 2017 $4,026,000 $461,000 $3,565,000. 2016 Face value December 31, 2016 $ 3,000,000 Debt discount at issuance (2,551,000 ) Amortization of debt discount since inception 669,000 2016 Senior Convertible Notes (net) $ 1,118,000 During 2016, $3 6% “2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. first The conversion rate of the notes was fixed at $0.25 August 25, 2016. 10% $0.25 ten 4 2 1934, 506 501 1933. In connection with the issuance of the 2016 1,200,000 $0.25 10 $28,000 2015 03 835 30 five The Company allocated $2,551,000 2016 March 31, 2018, $3,000,000 $1,882,000 $1,118,000. December 31, 2017, $3,000,000 $2,001,000 $999,000. During the three March 31, 2018, $163,000 $118,000. three March 31, 2017 $156,000 $112,000.

Note 5 - Software

Note 5 - Software	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 5 – SOFTWARE The Company invested in software for the CURA System during 2015. 3 three March 31, 2018 2017 $31,000 March 31, 2018 December 31, 2017 $71,000 $102,000, $71,000 2018.

Note 6 - Property and Equipment

Note 6 - Property and Equipment	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6 - PROPERTY AND EQUIPMENT At March 31, 2018 December 31, 2017 March 31, 2018 December 31, 2017 Office equipment $ 249,000 $ 249,000 Shop equipment 231,000 231,000 Leasehold improvements 253,000 253,000 733,000 733,000 Less accumulated depreciation (621,000 ) (608,000 ) Net property and equipment $ 112,000 $ 125,000 Depreciation expense for the three March 31, 2018 2017 $13,000 $15,000

Note 7 - Business Segments

Note 7 - Business Segments	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 7 - BUSINESS SEGMENTS The Company has two Segment information for the three ended March 31, 201 8 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 8,000 $ - $ - $ 8,000 Loss on Revenue 29,000 - - 29,000 Total Costs and Expenses 523,000 131,000 376,000 1,030,000 Loss from operations 552,000 131,000 376,000 1,059,000 Other expense - - (236,000 ) (236,000 ) Net loss $ 552,000 $ 131,000 $ 612,000 $ 1,295,000 Stock based compensation $ (16,000 ) $ 2,000 $ 16,000 $ 2,000 Depreciation and amortization $ 37,000 $ 5,000 $ 2,000 $ 44,000 Capital expenditures $ - $ - $ - $ - Assets at March 31, 2018 $ 1,860,000 $ 70,000 $ 227,000 $ 2,157,000 Segment information for the three ended March 31, 201 7 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 9,000 $ - $ - $ 9,000 Loss on revenue 28,000 - - 28,000 Total costs and expenses 758,000 132,000 428,000 1,318,000 Loss from operations 786,000 132,000 428,000 1,346,000 Other expense - - (155,000 ) (155,000 ) Net loss $ 786,000 $ 132,000 $ 583,000 $ 1,501,000 Stock based compensation $ 76,000 $ 2,000 $ 25,000 $ 103,000 Depreciation and amortization $ 37,000 $ 6,000 $ 3,000 $ 46,000 Capital expenditures $ 11,000 $ - $ - $ 11,000 Assets at March 31, 2017 $ 284,000 $ 42,000 $ 955,000 $ 1,281,000

Note 8 - Preferred and Common S

Note 8 - Preferred and Common Stock	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 8 - PREFERRED and COMMON STOCK Common Stock We have authorized 400,000,000 $0.01 During the three March 31, 2018 80,000 3 three March 31, 2017, 200,000 3 Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 Class A Preferred Stock At March 31, 2018 December 31, 2017, 468,221 8,709 no 459,512 $2,392,000 March 31, 2018 $2,346,000 December 31, 2017. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, Class A Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred stockholders’ liquidation preference was $2,392,000 $2,346,000 March 31, 2018 December 31, 2017, 1 $4.00 Class B Preferred Stock At March 31, 2018 December 31, 2017, 67,500 $429,000 March 31, 2018 $420,000 December 31, 2017. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders and our Class A Preferred stockholders, Class B Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred stockholders’ liquidation preference was $429,000 $420,000 March 31, 2018 December 31, 2017, 1 $5.00 Series C Preferred Stock At March 31, 2018 December 31, 2017, 15,937,500 $6,375,000 March 31, 2018 December 31, 2017. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 The Series C Preferred shares have no no Series C- 2 At March 31, 2018 December 31, 2017, 25,000,000 2 2 $5,000,000 March 31, 2018 December 31, 2017. The Series C- 2 not no 2 may not, two 2 2 2 2 2 2 2 2 not Series C- 3 The Company issued 6,042,000 3 2016, $1,495,000 three March 31, 2018 2017 80,000 200,000 3

Note 9 - Stock Options

Note 9 - Stock Options	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 9 - STOCK OPTIONS 2016 Stock Option Plan 2016 2016 “2016 3,000,000 may 2016 March 31, 2018, no 2011 Stock Option Plan 2011, 2011 “2011 3,000,000 may 2011 Under the 2016 2011 may may may may not 10% may not 110% ten 10% may not five During the three March 31, 2018, 150,000 $0.31 $.33 10 25% The expense recognized for options that are granted to consultants (i.e., non-employees) reflect fair value, based on updated valuation assumptions using the Black-Scholes valuation model at each measurement period. Such expense is apportioned over the requisite service period of the consultant, which is concurrent with the vesting dates of the various tranches. Non-Plan Options Summary three March 31, 2018 2017, $2,000 $103,000, first 2018, $29,000 March 31, 2018, $198,000 1.3 The weighted average grant date fair value of stock options granted during the three March 31, 2018 2017 $0.33 $0.76, three March 31, 2018 2017 $22,000 $2,000, The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2018 2017 Expected term (years) 6.3 6.6 Expected forfeiture rate 0 % 0 % Risk-free rate 2.6 % 2.1 % Volatility 130 % 130 % Dividend yield 0 % 0 % The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not The following summarizes the activity of all of our outstanding stock options as of March 31, 2018: Shares Weighted Average Exercise Price Average Remaining Contractual Term (years) Aggregate Intrinsic Value Outstanding at January 1, 2018 9,682,000 $ .54 Granted 150,000 .32 Exercised - - Canceled or expired (191,875 ) .39 Outstanding at March 31, 2018 9,640,125 $ .54 3.7 $ 114,000 Exercisable at March 31, 2018 6,490,375 $ .61 3.3 $ 2,000 No three March 31, 2018. three March 31, 2018, 191,875 March 31, 2018, 2,740,125 2011 1,740,375 259,875 2011 March 31, 2018, $.22 $1.58

Note 10 - Warrants

Note 10 - Warrants	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Stockholders Equity Note Warrants Or Rights [Text Block]	NOTE 1 0 - WARRANTS The following summarizes the activity of our outstanding warrants as of March 31, 2018: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2018 5,214,836 $ .57 (A) Granted 777,027 .33 Exercised - - Canceled or expired - - Outstanding at March 31, 2018 5,991,863 $ .53 (A) 6.5 (B) $ 189,000 Exercisable at March 31, 2018 5,366,863 $ .53 6.6 (C) $ 189,000 (A) The weighted average exercise price for warrants outstanding as of March 31, 2018 January 1, 2018 1,750,000 no (B) The weighted average remaining contractual term for warrants outstanding as of March 31, 2018 December 31, 2017 743,500 no (C) The weighted average remaining contractual term for warrants exercisable as of March 31, 2018, December 31, 2017 118,500 no

Note 11 - Related Party Transac

Note 11 - Related Party Transactions and Subsequent Events	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 1 1 - RELATED PARTY TRANSACTIONS AND SUBSEQUENT EVENTS We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which a Company director is associated. 2017 Subsequent to March 31, 2018, $150,000 2017 270,270 $50,000 2017 15,015 Preferred Shares Converted into Common Stock Subsequent to March 31, 2018, 750,000 250,000 500,000 2

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2018
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Consolidation: 56% March 31, 2018,
Use of Estimates, Policy [Policy Text Block]	Use of Estimates:
Reclassification, Policy [Policy Text Block]	Reclassifications: may
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash: may $15,000.
Inventory, Policy [Policy Text Block]	Inventory $6,000 March 31, 2018 December 31, 2017,
Receivables, Policy [Policy Text Block]	Accounts Receivable not zero March 31, 2018 December 31, 2017.
Software Property And Equipment [Policy Text Block]	Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in Other income. Depreciation and software amortization expense for the three March 31, 2018 2017 $44,000 $46,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may During the three March 31, 2018 March 31, 2017 no
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 March 31, 2018 December 31, 2017. 6% $7,949,000 March 31, 2018 March 31, 2018.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. not not two The Company's net revenue is derived primarily from domestic customers. For the three March 31, 2018 $4,000 $4,000. Revenue from the sale of CURA System products is recognized upon the shipment of myCadian devices to a customer and upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30 One customer accounted for 87% three March 31, 2018. 30
In Process Research and Development, Policy [Policy Text Block]	Engineering and Development and Patents: Patent costs for the three March 31, 2018 March 31, 2017 $31,000 $30,000,
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-based Compensation: 718 10 718 10. No FASB ASC 505 50, FASB ASC 718 20
Income Tax, Policy [Policy Text Block]	Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not March 31, 2018, December 31, 2017, no
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share: 260 10 March 31, 2018 2017 84,560,427 72,282,657 625,000 March 31, 2018 2017 not
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements : In May 2017, No. 2017 09 718 December 15, 2017 not In June 2016, No. 2016 13 326 not December 15, 2019, not On February 25, 2016, No. 2016 02, December 15, 2018, not

Note 2 - Summary of Significa19

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Software, Property and Equipment Estimated Useful Life [Table Text Block]	Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term

Note 3 - Inventory and Relate20

Note 3 - Inventory and Related Vendor Liability (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Inventory, Current [Table Text Block]	March 31, December 31, 2018 2017 Raw materials $ 1,681,000 $ 1,681,000 Finished goods 66,000 69,000 1,747,000 1,750,000 Less: Reserve for quality (6,000 ) (6,000 ) Inventory (net) $ 1,741,000 $ 1,744,000 Liability for inventory held at vendor $ 1,512,000 $ 1,678,000

Note 4 - 6% Senior Convertibl21

Note 4 - 6% Senior Convertible Notes and Warrants (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Convertible Debt [Table Text Block]	Face value of 2017 Convertible Notes $ 4,026,000 Debt discount at issuance (1,743,000 ) 2017 extinguishment impact on discount 1,183,000 Amortization of debt discount since inception 99,000 2017 Senior Convertible Notes (net) $ 3,565,000 Face value December 31, 2016 $ 3,000,000 Debt discount at issuance (2,551,000 ) Amortization of debt discount since inception 669,000 2016 Senior Convertible Notes (net) $ 1,118,000

Note 6 - Property and Equipme22

Note 6 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, 2018 December 31, 2017 Office equipment $ 249,000 $ 249,000 Shop equipment 231,000 231,000 Leasehold improvements 253,000 253,000 733,000 733,000 Less accumulated depreciation (621,000 ) (608,000 ) Net property and equipment $ 112,000 $ 125,000

Note 7 - Business Segments (Tab

Note 7 - Business Segments (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	CURA Aegis Corporate Total Revenue $ 8,000 $ - $ - $ 8,000 Loss on Revenue 29,000 - - 29,000 Total Costs and Expenses 523,000 131,000 376,000 1,030,000 Loss from operations 552,000 131,000 376,000 1,059,000 Other expense - - (236,000 ) (236,000 ) Net loss $ 552,000 $ 131,000 $ 612,000 $ 1,295,000 Stock based compensation $ (16,000 ) $ 2,000 $ 16,000 $ 2,000 Depreciation and amortization $ 37,000 $ 5,000 $ 2,000 $ 44,000 Capital expenditures $ - $ - $ - $ - Assets at March 31, 2018 $ 1,860,000 $ 70,000 $ 227,000 $ 2,157,000 CURA Aegis Corporate Total Revenue $ 9,000 $ - $ - $ 9,000 Loss on revenue 28,000 - - 28,000 Total costs and expenses 758,000 132,000 428,000 1,318,000 Loss from operations 786,000 132,000 428,000 1,346,000 Other expense - - (155,000 ) (155,000 ) Net loss $ 786,000 $ 132,000 $ 583,000 $ 1,501,000 Stock based compensation $ 76,000 $ 2,000 $ 25,000 $ 103,000 Depreciation and amortization $ 37,000 $ 6,000 $ 3,000 $ 46,000 Capital expenditures $ 11,000 $ - $ - $ 11,000 Assets at March 31, 2017 $ 284,000 $ 42,000 $ 955,000 $ 1,281,000

Note 9 - Stock Options (Tables)

Note 9 - Stock Options (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2018 2017 Expected term (years) 6.3 6.6 Expected forfeiture rate 0 % 0 % Risk-free rate 2.6 % 2.1 % Volatility 130 % 130 % Dividend yield 0 % 0 %
Share-based Compensation, Stock Options, Activity [Table Text Block]	Shares Weighted Average Exercise Price Average Remaining Contractual Term (years) Aggregate Intrinsic Value Outstanding at January 1, 2018 9,682,000 $ .54 Granted 150,000 .32 Exercised - - Canceled or expired (191,875 ) .39 Outstanding at March 31, 2018 9,640,125 $ .54 3.7 $ 114,000 Exercisable at March 31, 2018 6,490,375 $ .61 3.3 $ 2,000

Note 10 - Warrants (Tables)

Note 10 - Warrants (Tables)	3 Months Ended
	Mar. 31, 2018
Warrant [Member]
Notes Tables
Share-based Compensation, Activity [Table Text Block]	Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2018 5,214,836 $ .57 (A) Granted 777,027 .33 Exercised - - Canceled or expired - - Outstanding at March 31, 2018 5,991,863 $ .53 (A) 6.5 (B) $ 189,000 Exercisable at March 31, 2018 5,366,863 $ .53 6.6 (C) $ 189,000

Note 1 - The Company and Basi26

Note 1 - The Company and Basis of Presentation (Details Textual)	3 Months Ended
	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Number of Operating Segments	2
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 192,000	$ 194,000	$ 892,000	$ 2,009,000
Working Capital	20,000
Stockholders' Equity Attributable to Parent, Ending Balance	(4,482,000)	(3,408,000)
Retained Earnings (Accumulated Deficit), Ending Balance	(82,136,000)	$ (80,841,000)
Proceeds From Convertible Debt, Gross	1,200,000
Minimum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	4,500,000
Maximum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	$ 5,000,000
The 2017 Convertible Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%

Note 2 - Summary of Significa27

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Inventory Valuation Reserves, Ending Balance	$ 6,000		$ 6,000
Allowance for Doubtful Accounts Receivable, Current, Ending Balance	0		0
Depreciation, Depletion and Amortization, Total	44,000	$ 46,000
Capitalized Computer Software, Impairments	0	0
Revenue from Contract with Customer, Including Assessed Tax	8,000	9,000
Research and Development Expense, Total	405,000	$ 493,000
Excess Tax Benefit from Share-based Compensation, Operating Activities	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total	$ 0		$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	84,560,427	72,282,657
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	625,000	625,000
Patents [Member] | General and Administrative Expense [Member]
Research and Development Expense, Total	$ 31,000	$ 30,000
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage	87.00%
Z-Coach Aviation Wellness Program Annual Subscription [Member]
Deferred Revenue Arrangement, Subscription Period	1 year
Transferred over Time [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 4,000
Transferred at Point in Time [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 4,000
Senior Convertible Promissory Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Long-term Debt, Fair Value	$ 7,949,000
Commercial Paper [Member] | Collateral Pledged [Member]
Debt Instrument, Collateral Amount	$ 15,000
Subsidiaries [Member]
Equity Method Investment, Ownership Percentage	56.00%

Note 2 - Summary of Significa28

Note 2 - Summary of Significant Accounting Policies - Property, and Equipment, Estimated Useful Lives (Details)	3 Months Ended
	Mar. 31, 2018
Office Equipment [Member] | Minimum [Member]
Property plant and equipment, useful lives (Year)	5 years
Office Equipment [Member] | Maximum [Member]
Property plant and equipment, useful lives (Year)	7 years
Leasehold Improvements [Member]
Property plant and equipment, useful lives	lesser of useful life or lease term
Computer Software, Intangible Asset [Member]
Property plant and equipment, useful lives (Year)	3 years

Note 3 - Inventory and Relate29

Note 3 - Inventory and Related Vendor Liability (Details Textual) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Inventory, Raw Materials, Gross, Total	$ 1,681,000	$ 1,681,000
Liability for Inventory Held at Vendor	$ 1,512,000	$ 1,678,000

Note 3 - Inventory and Relate30

Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Raw materials	$ 1,681,000	$ 1,681,000
Finished goods	66,000	69,000
	1,747,000	1,750,000
Less: Reserve for quality	(6,000)	(6,000)
Inventory (net)	1,741,000	1,744,000
Liability for inventory held at vendor	$ 1,512,000	$ 1,678,000

Note 4 - 6% Senior Convertibl31

Note 4 - 6% Senior Convertible Notes and Warrants (Details Textual)	Nov. 30, 2017USD ($)$ / shares	May 31, 2017$ / shares	Aug. 25, 2016$ / shares	Mar. 31, 2018USD ($)shares	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2017USD ($)
Interest Expense, Total				$ 237,000	$ 156,000
Amortization of Debt Discount (Premium)				139,000	112,000
Warrants Related to the 2017 Convertible Notes [Member]
Investment Threshold				$ 500,000
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold				10.00%
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes				25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.333	$ 0.50
Class of Warrant or Right, Term		10 years
Warrants Related to the 2016 Convertible Notes [Member]
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes			10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.25			$ 0.25
Class of Warrant or Right, Term						10 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						1,200,000
The 2017 Convertible Notes [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement				$ 5,000,000
Debt Instrument, Interest Rate, Stated Percentage				6.00%
Debt Instrument, Term				5 years
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.333	$ 0.50
Convertible Notes, Aggregate Amount Reissued	$ 2,450,000
Debt Instrument, Face Amount				$ 1,200,000
Debt Instrument, Convertible, Number of Equity Instruments				3,603,604
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				777,027
Debt Instrument, Debt Discount Before Amortization				$ 219,000
Interest Expense, Total				74,000
Amortization of Debt Discount (Premium)				21,000
Long-term Debt, Gross				4,026,000	4,026,000
Debt Instrument, Unamortized Discount, Total				461,000	461,000
Long-term Debt, Total				3,565,000	3,565,000
The 2016 Convertible Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage						6.00%
Debt Instrument, Term			5 years			5 years
Debt Instrument, Convertible, Conversion Price | $ / shares			$ 0.25
Debt Instrument, Face Amount				3,000,000			$ 3,000,000
Debt Instrument, Debt Discount Before Amortization						$ 2,551,000
Interest Expense, Total				163,000	156,000
Amortization of Debt Discount (Premium)				118,000	$ 112,000
Long-term Debt, Gross				3,000,000
Debt Instrument, Unamortized Discount, Total				1,882,000			2,001,000
Long-term Debt, Total				$ 1,118,000			$ 999,000
Debt Issuance Costs, Net, Total						28,000
The 2016 Convertible Notes [Member] | Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement						$ 3,000,000

Note 4 - 6% Senior Convertibl32

Note 4 - 6% Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017
The 2017 Convertible Notes [Member]
Face value of Convertible Notes	$ 4,026,000		$ 4,026,000
Debt discount at issuance	(1,743,000)
2017 extinguishment impact on discount	1,183,000
Amortization of debt discount since inception	99,000
2017 Senior Convertible Notes (net)	3,565,000		3,565,000
Face value of Convertible Notes	4,026,000		$ 4,026,000
The 2016 Convertible Notes [Member]
Face value of Convertible Notes	3,000,000
Debt discount at issuance	(2,551,000)
Amortization of debt discount since inception	669,000
2017 Senior Convertible Notes (net)	1,118,000	$ 999,000
Face value of Convertible Notes	$ 3,000,000

Note 5 - Software (Details Text

Note 5 - Software (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Capitalized Computer Software, Amortization	$ 31,000	$ 31,000
Capitalized Computer Software, Net, Ending Balance	$ 71,000		$ 102,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	3 years
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	$ 71,000

Note 6 - Property and Equipme34

Note 6 - Property and Equipment (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Depreciation, Total	$ 13,000	$ 15,000

Note 6 - Property and Equipme35

Note 6 - Property and Equipment - Property and Equipment (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Office equipment	$ 249,000	$ 249,000
Shop equipment	231,000	231,000
Leasehold improvements	253,000	253,000
	733,000	733,000
Less accumulated depreciation	(621,000)	(608,000)
Net property and equipment	$ 112,000	$ 125,000

Note 7 - Business Segments (Det

Note 7 - Business Segments (Details Textual)	3 Months Ended
	Mar. 31, 2018
Number of Operating Segments	2

Note 7 - Business Segments - Op

Note 7 - Business Segments - Operation by Segments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Revenue	$ 8,000	$ 9,000
Loss on Revenue	29,000	28,000
Total Costs and Expenses	1,030,000	1,318,000
Loss from operations	1,059,000	1,346,000
Other expense	(236,000)	(155,000)
Net loss	1,295,000	1,501,000
Stock based compensation	2,000	103,000
Depreciation and amortization	44,000	46,000
Capital expenditures		11,000
Assets	2,157,000	1,281,000	$ 2,200,000
Other expense	(236,000)	(155,000)
Operating Segments [Member] | CURA Division [Member]
Revenue	8,000	9,000
Loss on Revenue	29,000	28,000
Total Costs and Expenses	523,000	758,000
Loss from operations	552,000	786,000
Other expense
Net loss	552,000	786,000
Stock based compensation	(16,000)	76,000
Depreciation and amortization	37,000	37,000
Capital expenditures		11,000
Assets	1,860,000	284,000
Other expense
Operating Segments [Member] | Aegis Division [Member]
Revenue
Loss on Revenue
Total Costs and Expenses	131,000	132,000
Loss from operations	131,000	132,000
Other expense
Net loss	131,000	132,000
Stock based compensation	2,000	2,000
Depreciation and amortization	5,000	6,000
Capital expenditures
Assets	70,000	42,000
Other expense
Corporate, Non-Segment [Member]
Revenue
Loss on Revenue
Total Costs and Expenses	376,000	428,000
Loss from operations	376,000	428,000
Other expense	(236,000)	(155,000)
Net loss	612,000	583,000
Stock based compensation	16,000	25,000
Depreciation and amortization	2,000	3,000
Capital expenditures
Assets	227,000	955,000
Other expense	$ (236,000)	$ (155,000)

Note 8 - Preferred and Common38

Note 8 - Preferred and Common Stock (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017	Dec. 31, 2016
Common stock, shares authorized (in shares)	400,000,000		400,000,000
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000		100,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01		$ 0.01
Preferred Class A [Member]
Preferred stock, shares outstanding (in shares)	468,221		468,221
Preferred Stock Dividends, Shares	8,709		8,709
Dividends Payable	$ 2,392,000		$ 2,346,000
Preferred Stock, Liquidation Preference, Value	$ 2,392,000		$ 2,346,000
Preferred Stock, Liquidation Preference Per Share	$ 4
Preferred Class B [Member]
Preferred stock, shares outstanding (in shares)	67,500		67,500
Dividends Payable	$ 429,000		$ 420,000
Preferred Stock, Liquidation Preference, Value	$ 429,000		$ 420,000
Preferred Stock, Liquidation Preference Per Share	$ 5
Series C Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	15,937,500		15,937,500
Preferred Stock, Liquidation Preference, Value	$ 6,375,000		$ 6,375,000
Preferred Stock, Liquidation Preference Per Share	$ 0.40
Series C2 Preferred Stock [Member]
Preferred stock, shares outstanding (in shares)	25,000,000		25,000,000
Preferred Stock, Liquidation Preference, Value	$ 5,000,000		$ 5,000,000
Series C3 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	80,000	200,000
Stock Issued During Period, Shares, New Issues				6,042,000
Preferred stock, shares outstanding (in shares)	3,308,000		3,388,000
Proceeds from Issuance of Private Placement, Net				$ 1,495,000
Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	80,000
Common Stock [Member] | Conversion of Series C3 Convertible Stock Into Common Stock [Member]
Stock Issued During Period, Shares, New Issues		200,000
Common Stock [Member] | Conversion of Series C3 Convertible Stock Into Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	80,000

Note 9 - Stock Options (Details

Note 9 - Stock Options (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2011	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	150,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 0.22
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 1.58
Allocated Share-based Compensation Expense, Total	$ 2,000	$ 103,000
Stock Issued During Period, Value, Share-based Compensation, Forfeited	29,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total	$ 198,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 109 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.33	$ 0.76
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 22,000	$ 2,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period	191,875
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	9,640,125			9,682,000
Stock Option Plan 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0
Stock Option Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum			10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date			110.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years		10 years
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 0.31
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 0.33
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	2,740,125
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	1,740,375
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	259,875

Note 9 - Stock Options - Stock

Note 9 - Stock Options - Stock Options Valuation Assumptions (Details)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Expected term (years) (Year)	6 years 109 days	6 years 219 days
Expected forfeiture rate	0.00%	0.00%
Risk-free rate	2.60%	2.10%
Volatility	130.00%	130.00%
Dividend yield	0.00%	0.00%

Note 9 - Stock Options - Share-

Note 9 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Outstanding shares (in shares)	9,682,000
Outstanding - weighted average exercise price (in dollars per share)	$ 0.54
Outstanding - weighted average remaining contractual term (Year)	3 years 255 days
Outstanding - aggregate intrinsic value	$ 114,000
Shares, granted (in shares)	150,000
Weighted average exercise price, granted (in dollars per share)	$ 0.32
Shares, exercised (in shares)	0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)	(191,875)
Weighted average exercise price, canceled or expired (in dollars per share)	$ 0.39
Outstanding shares (in shares)	9,640,125	9,682,000
outstanding - weighted average exercise price (in dollars per share)	$ 0.54	$ 0.54
Shares, exercisable (in shares)	6,490,375
Weighted average exercise price, exercisable (in dollars per share)	$ 0.61
Exercisable- weighted average remaining contractual term (Year)	3 years 109 days
Exercisable-aggregate intrinsic value	$ 2,000

Note 10 - Warrants (Details Tex

Note 10 - Warrants (Details Textual) - shares	Mar. 31, 2018	Dec. 31, 2017
Warrants without Expiration Date, Outstanding	743,500	743,500
Warrants without Expiration Date, Exercisable	118,500	118,500
Warrants Not Determined, Exercise Price [Member]
Class of Warrant or Right, Outstanding	1,750,000	1,750,000

Note 10 - Warrants - Summary of

Note 10 - Warrants - Summary of Outstanding Warrants (Details) - USD ($)		3 Months Ended		12 Months Ended
		Mar. 31, 2018		Dec. 31, 2017
Outstanding shares (in shares)		9,682,000
Outstanding - weighted average exercise price (in dollars per share)		$ 0.54
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		150,000
Weighted average exercise price, granted (in dollars per share)		$ 0.32
Shares, exercised (in shares)		0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)		(191,875)
Weighted average exercise price, canceled or expired (in dollars per share)		$ 0.39
Outstanding shares (in shares)		9,640,125		9,682,000
outstanding - weighted average exercise price (in dollars per share)		$ 0.54		$ 0.54
Shares, exercisable (in shares)		6,490,375
Weighted average exercise price, exercisable (in dollars per share)		$ 0.61
Exercisable - weighted average remaining contractual term (Year)		3 years 109 days
Exercisable - aggregate intrinsic value		$ 2,000
Warrant [Member]
Outstanding shares (in shares)		5,214,836
Outstanding - weighted average exercise price (in dollars per share)	[1]	$ 0.57
Outstanding - weighted average remaining contractual term (Year)		6 years 182 days	[2]
Outstanding - aggregate intrinsic value		$ 189,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		777,027
Weighted average exercise price, granted (in dollars per share)		$ 0.33
Shares, exercised (in shares)
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)
Weighted average exercise price, canceled or expired (in dollars per share)
Outstanding shares (in shares)		5,991,863		5,214,836
outstanding - weighted average exercise price (in dollars per share)	[1]	$ 0.53		$ 0.57
Shares, exercisable (in shares)		5,366,863
Weighted average exercise price, exercisable (in dollars per share)		$ 0.53
Exercisable - weighted average remaining contractual term (Year)	[3]	6 years 219 days
Exercisable - aggregate intrinsic value		$ 189,000
[1]	The weighted average exercise price for warrants outstanding as of March 31, 2018 and January 1, 2017 excludes 1,750,000 warrants in each period with no determined exercise price.
[2]	The weighted average remaining contractual term for warrants outstanding as of March 31, 2018 and December 31, 2017 excludes 743,500 warrants with no expiration date.
[3]	The weighted average remaining contractual term for warrants exercisable as of March 31, 2018, and December 31, 2017 excludes 118,500 warrants with no expiration date.

Note 11 - Related Party Trans44

Note 11 - Related Party Transactions and Subsequent Events (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	May 08, 2018	Mar. 31, 2018
Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		80,000
Subsequent Event [Member] | Series C Preferred Stock [Member]
Conversion of Stock, Shares Converted	250,000
Subsequent Event [Member] | Series C2 Preferred Stock [Member]
Conversion of Stock, Shares Converted	500,000
Subsequent Event [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	750,000
Chief Executive Officer [Member] | Subsequent Event [Member] | Warrants Related to the 2017 Convertible Notes [Member]
Class Of Warrant Or Right Issued In Period	270,270
Director [Member] | Subsequent Event [Member] | Warrants Related to the 2017 Convertible Notes [Member]
Class Of Warrant Or Right Issued In Period	15,015
The 2017 Convertible Notes [Member]
Debt Instrument, Face Amount		$ 1,200,000
The 2017 Convertible Notes [Member] | Chief Executive Officer [Member] | Subsequent Event [Member]
Debt Instrument, Face Amount	$ 150,000
The 2017 Convertible Notes [Member] | Director [Member] | Subsequent Event [Member]
Debt Instrument, Face Amount	$ 50,000